H. Ralph Snodgrass

PRES./CHIEF SCIENTIFIC OFFICER, Vistagen Therapeutics, Inc.

Companies

Vistagen Therapeutics, Inc.PRES./CHIEF SCIENTIFIC OFFICER May 25, 2011 to Sep 3, 2021¹
Vistagen Therapeutics, Inc.Board member Dec 22, 2011 to Jan 4, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vistagen Therapeutics, Inc. VTGN98,859 shares³$21.0K at $0.21Jan 3, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 31, 2021Granted 3,623 shares at $1.66 of Vistagen Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVistagen Therapeutics, Inc., PRES./CHIEF SCIENTIFIC OFFICER
2
SEC EDGARVistagen Therapeutics, Inc., Board member
3
SEC EDGARVistagen Therapeutics, Inc. shares after the filing of Jan 3, 2022